Picture of BioLine RX logo

BLRX BioLine RX Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for BioLine RX, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments49.530.227.522.657.1
Net Total Receivables0.5861.340.6130.1410.142
Prepaid Expenses
Total Current Assets50.43228.222.957.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment2.52.233.472.72.28
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets6156.253.647.381.4
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities6.726.751210.69.72
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities8.0814.920.225.313.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity52.941.333.42268.1
Total Liabilities & Shareholders' Equity6156.253.647.381.4
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email